About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers, and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
This briefing was developed for NICE by Cedar. The interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality assured and approved for publication.
Dr Alistair Ray, Research Associate, Cedar
Andrew Cleves, Researcher, Cedar
Dr Grace Carolan‑Rees, Director, Cedar
The following specialist commentators provided comments on a draft of this briefing:
Dean Linzey (Nurse Consultant, Viral Hepatology, Royal Berkshire Hospital)
Prof John Geen (Consultant Clinical Biochemist, Cwm Taf University Health Board)
Melinda Kemp (BBV Nurse Specialist [Community] Worcestershire Royal Hospital)
Sam Ray (Health Protection Nurse, Public Health Wales)
© National Institute for Health and Care Excellence 2015. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not‑for‑profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.